Clinical Trial: SPY003-207 in Health Volunteers

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06873724) titled 'SPY003-207 in Health Volunteers' on March 07.

Brief Summary: This is a Phase 1, randomized, double-blind, placebo-controlled, single dose, first in human safety, tolerability, and pharmacokinetic study of SPY003-207 in healthy participants.

Study Start Date: March 10

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: SPY003-207

Experimental

OTHER: Placebo

Placebo

Recruitment Status: RECRUITING

Sponsor: Spyre Therapeutics, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....